in contrast , 30 approximately 54 % ( 1.02 approximately 3.85 nmol/dl gf ) of ncamp , which was greater than the diurnal variation , was suppressed after calcium injection in 5 patients with primary hyperparathyroidism ( 2 of 4 patients with urological , and 3 of 5 patients with chemical hyperparathyroidism ) .
C0221002
primary hyperparathyroidism
C0020502
hyperparathyroidism